Gauging Change in Europe’s Sterile Manufacturing Market

Colin MacKay, CEO of Symbiosis Pharmaceutical Services discusses ‘Gauging Change in Europe’s Sterile Manufacturing Market’ in this guest blog as featured on PharmTech.com.The past six months has seen some major changes to the sterile manufacturing landscape in Europe. There have been a number of exits and acquisitions that have no doubt grabbed headlines, but has anything really changed?At an industry level, the… Read More

Au revoir CPhI Paris

From the 7th until the 10th October the Symbiosis team attended CPhI, one of Europe’s largest pharmaceutical conferences held in Paris, France. Our two European Business Development Managers and our CEO were in attendance at the event with support from our friends at Scottish Development International. Thanks to those of you who visited our stand, especially given the challenges of navigating the… Read More

Symbiosis’ BIO 2014 Experience

For the Symbiosis team attending BIO 2014, the conference started in true BIO style with a spectacular welcome reception on the deck of the USS Midway Museum (below), involving great networking, good food, some lively entertainment, and a dash of maritime education. The evening came to an end as the San Diego bay shoreline was lit up by a BIO fireworks display… Read More

The Huge Potential of Antibody – Drug Conjugates

Symbiosis Pharmaceutical Services recently attended the World ADC conference in Frankfurt.  There, we were pleased to see 250 attendees from all over the world sharing ideas and reporting their experiences on the progress of ADC development. In combination with the event, World ADC published an insightful market research report  which is available for download by clicking the following link:-http://adcsummit-europe.com/uploads/ffiles/2014/01/659869.pdf.  This article illustrates… Read More

Insight into RABs Cabinets

RABS’ cabinets or Restricted Access Barrier Systems on a vertical Laminar Airflow cabinet are widely used in aseptic processing. These systems offer a flexible way of working over sanitised isolators and they negate the need for the use of sanitising agents such as hydrogen peroxide that may adverse impact the product or monitoring process. When working within a RABS, manual operations are… Read More

QP for GMP ASAP?

Recent reports in the media (http://www.in-pharmatechnologist.com/Regulatory-Safety/A-QP-for-GMP-That-is-the-suggestion-IRCA-launches-pharma-auditor-training) are suggesting that GMP auditors should have an equivalent professional qualification similar to that of a QP.  At Symbiosis, we asked our QA department what they think about this idea.  Murray McKay, QA director at Symbiosis with over 25 yrs experience said “This idea is not a new one.  I can see that a certain level… Read More

Review of 2013 and Seasons Greetings from our CEO

As we near the end of 2013, it’s the perfect time to reflect on what has been a remarkable year not only for Symbiosis but for the wider pharmaceutical services industry. We’ve noted some very positive signs of growth in the world of drug development services, and several of them align clearly with the strategic focus of Symbiosis Pharmaceutical Services. They include… Read More

Get In Touch